Prognosis For Sarcomatoid Mesothelioma, B7 H1 Expression In Malignant Pleural Mesothelioma Is Associated With Sarcomatoid Histology And Poor Prognosis Journal Of Thoracic Oncology

The average life expectancy for patients with the sarcomatoid cell type is just 4 months.

Gis mesothelioma. Studies have shown life expectancies ranging from one month to about 28 months. Even with quick treatment at the first sight of symptoms the average survival for sarcomatoid patients is only around 1 year or less. Mesothelioma is rare cancer with only 3000 cases diagnosed annually but the prognosis is poor.

This is part of the reason for the survival statistics of this disease. The average sarcomatoid mesothelioma survival rate is around six months from the time of diagnosis. Type of mesothelioma stage of disease and overall health.

Sarcomatoid cancer cells spread quickly making tumors resistant to many standard treatment options. For patients who receive treatment the prognosis can improve to 1 2 years. Sarcomatoid mesothelioma is the least common and is often referred to as cell type or spindle cell mesothelioma.

Of the different types of mesothelioma the sarcomatoid type has the worst prognosis due to its aggressive nature and poor response to treatment. It also depends on the stage of mesothelioma when diagnosed. Many cases of sarcomatoid mesothelioma are resistant to treatment.

Prognosis of sarcomatoid mesothelioma. Mesothelioma prognosis is determined by a doctor and is the likely outcome of the disease and overall life expectancy. Sarcomatoid mesothelioma has the least favorable prognosis compared to the other common cell types.

Most patients will live for about six months. It is estimated that 20 of mesothelioma cases are of this type. However there are some patients that have lived for up to six years.

Mesothelioma cancer is aggressive. The prognosis disease outlook for patients with sarcomatoid mesothelioma is not as good as it is for mesothelioma patients with other cell types. A mesothelioma prognosis may vary depending on the general age gender and health of the patient.

Sarcomatoid cell mesothelioma does not have as positive a prognosis as other cell types. Patients with sarcomatoid mesothelioma face a significantly worse prognosis. The majority of patients face a median survival of six months or less.

Prognosis sarcomatoid mesothelioma prognosis. Sarcomatoid mesothelioma has the least. Mixed tumors that contain more epithelioid cells have a better prognosis than those that contain more sarcomatoid cells.

Sarcomatoid mesothelioma has the poorest prognosis of the three cell types. On average mesothelioma patients survive 12 to 21 months.